About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have three novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

January 6, 2017

DS Biopharma (DS) announces that recruitment has begun in two separate Phase 2b atopic dermatitis studies with lead compound DS107 as well as the successful completion of a Phase 1 trial for follow on compound DS109

Dublin, Ireland, 6th January, 2017: DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in […]
November 28, 2016

DS Biopharma to present at Piper Jaffray 28th Annual Healthcare Conference

Dublin, Ireland, 28th November, 2016: DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present an overview of the […]

Join our mailing list

Connect with us